A detailed history of Studio Investment Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Studio Investment Management LLC holds 43,611 shares of MRK stock, worth $4.33 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
43,611
Previous 43,453 0.36%
Holding current value
$4.33 Million
Previous $5.38 Million 7.94%
% of portfolio
1.07%
Previous 1.24%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $17,561 - $20,377
158 Added 0.36%
43,611 $4.95 Million
Q2 2024

Aug 07, 2024

SELL
$123.8 - $132.96 $2,104 - $2,260
-17 Reduced 0.04%
43,453 $5.38 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $74,738 - $87,086
-660 Reduced 1.5%
43,470 $5.74 Million
Q4 2023

Feb 15, 2024

SELL
$100.18 - $109.02 $316,869 - $344,830
-3,163 Reduced 6.69%
44,130 $4.81 Million
Q3 2023

Nov 15, 2023

SELL
$102.95 - $114.33 $210,018 - $233,233
-2,040 Reduced 4.14%
47,293 $4.87 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $212,441 - $231,551
-1,956 Reduced 3.81%
49,333 $5.69 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $349,790 - $390,294
-3,398 Reduced 6.21%
51,289 $5.46 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $190,444 - $244,175
-2,178 Reduced 3.83%
54,687 $6.07 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $580,721 - $652,375
-6,870 Reduced 10.78%
56,865 $4.9 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $191,192 - $216,725
-2,290 Reduced 3.47%
63,735 $5.81 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $31,976 - $35,844
435 Added 0.66%
66,025 $5.42 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $170,219 - $213,221
2,355 Added 3.72%
65,590 $5.03 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $4.53 Million - $4.98 Million
63,235 New
63,235 $4.75 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Studio Investment Management LLC Portfolio

Follow Studio Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Studio Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Studio Investment Management LLC with notifications on news.